InvestorsObserver
×
News Home

Does 180 Life Sciences Corp (ATNF) Have What it Takes to be in Your Portfolio Monday?

Monday, April 17, 2023 11:29 AM | InvestorsObserver Analysts

Mentioned in this article

Does 180 Life Sciences Corp (ATNF) Have What it Takes to be in Your Portfolio Monday?

180 Life Sciences Corp (ATNF) is near the middle in its industry group according to InvestorsObserver. ATNF gets an overall rating of 52. That means it scores higher than 52 percent of stocks. 180 Life Sciences Corp gets a 59 rank in the Biotechnology industry. Biotechnology is number 29 out of 148 industries.

Overall Score - 52
ATNF has an Overall Score of 52. Find out what this means to you and get the rest of the rankings on ATNF!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 52 would rank higher than 52 percent of all stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With 180 Life Sciences Corp Stock Today?

180 Life Sciences Corp (ATNF) stock has gained 5.65% while the S&P 500 is down -0.03% as of 11:28 AM on Monday, Apr 17. ATNF has risen $0.07 from the previous closing price of $1.24 on volume of 180,752 shares. Over the past year the S&P 500 has fallen -5.81% while ATNF is down -96.48%. ATNF lost -$20.38 per share the over the last 12 months. Click Here to get the full Stock Report for 180 Life Sciences Corp stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App